Don't get excited about ph1 trials imugene acquired her-vaxx after ph1 and stated in 2014 ph2 trials will begin within 12months in 2019 first patient was dosed and now 10years later clinical trials are complete for IMU-131 Her-vaxx and all you hear is crickets no deals or rumors of talks even. what makes anyone think anything else in the pipeline will be any different there timeline has always been way longer than stated leading to loss of faith and since it's radio silence on Her-vaxx I'd say there's cause for lack of faith now, that said I made good money, but unless there's a marketing deal for Her-vaxx there can only be dilution awaiting completion of other trials,......stop dreaming of 3/6/9months wake up.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)